ABOUT K
ACADEMICS
ADMISSION
ALUMNI RELATIONS
GIVING TO K
NEWS & EVENTS
STUDENT LIFE
HORNET HIVE
ATHLETICS
SITEMAP
WEBMAIL
    • Login
    View Item 
    •   DSpace Home
    • Academic Departments, Programs, and SIPs
    • Chemistry
    • Chemistry Senior Individualized Projects
    • View Item
    •   DSpace Home
    • Academic Departments, Programs, and SIPs
    • Chemistry
    • Chemistry Senior Individualized Projects
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Analysis of Mechanism-Based Inhibition of Human Cytochrome P450 2D6 by Schering 66712

    Thumbnail
    View/Open
    non-printable PDF, Kalamazoo College only (409.5Kb)
    Date
    2009
    Author
    Mocny, Catherine S.
    Metadata
    Show full item record
    Abstract
    Cytochrome P450 2D6 (P450 2D6) makes up less than 5% of P450s found in the liver but is responsible for metabolism of 20-30% of drugs currently on the market. Inhibition of P450 2D6 due to adverse drug reactions or drug-drug interactions can lead to side effects from taking the recommended drug dosage or to side effects of taking more than one drug at once, respectively. Adverse drug reactions and drug-drug interactions are potentially fatal and therefore understanding inhibition is vital. The inhibition of human P450 2D6 by human D4 dopamine receptor antagonist, Schering 66712 ([5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine]) was analyzed to determine the mechanism for inactivation. By measuring loss of bufuralol 1’hydroxylation activity following coincubation of P450 2D6 with SCH 66712 a partition ratio of ~305 was determined. P450 2D6 inactivation was not protected by the addition of an exogenous nucleophile, potassium cyanide. The time dependent inactivation of P450 2D6 by SCH 66712 showed ~100% decrease in 1’OH bufuralol formation after 60 minutes in addition to an unequivocal loss of ~40% ability to bind carbon monoxide after 40 minutes. These findings support that inactivation of P450 2D6 by SCH 66712 occurs by adduction to protein rather than to the heme. Examination of possible SCH 66712 metabolites produced by P450 3A4 yielded no leads. Initial mass spectrometry analysis of P450s 3A4 and 2D6 gave intact protein masses of 56894 and 56936 Da, respectively.
    URI
    http://hdl.handle.net/10920/12076
    Collections
    • Chemistry Senior Individualized Projects [827]

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

    My Account

    Login

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
     

     

    K logo
    Kalamazoo College
    1200 Academy Street
    Kalamazoo Michigan 49006-3295
    USA
    Info 269-337-7000
    Admission 1-800-253-3602
    ABOUT K
    ACADEMICS
    ADMISSION
    ALUMNI RELATIONS
    GIVING TO K
    NEWS & EVENTS
    STUDENT LIFE

    Sitemap
    Map and Directions
    Contacts
    Directories
    Nondiscrimination Policy
    Consumer Information
    Official Disclaimer
    Search this site





    Academic Calendars
    Apply
    Bookstore
    Crisis Response
    Employment
    Library
    Registrar